Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 17.14
- Piotroski Score 2.00
- Grade Buy
- Symbol (DAWN)
- Company Day One Biopharmaceuticals, Inc.
- Price $13.71
- Changes Percentage (2.77%)
- Change $0.37
- Day Low $13.28
- Day High $13.91
- Year High $18.07
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/24/2025
- Fiscal Year End N/A
- Average Stock Price Target $40.00
- High Stock Price Target $45.00
- Low Stock Price Target $24.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.50
- Trailing P/E Ratio -5.11
- Forward P/E Ratio -5.11
- P/E Growth -5.11
- Net Income $-188,917,000
Income Statement
Quarterly
Annual
Latest News of DAWN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Watch the realization dawn on this birthday boy listen to his dreams come true on the radio
Benjamin Izzard received a surprise birthday gift of Imagine Dragons tickets from his family. The news was revealed on the radio by Sarah Champion, leaving Benjamin ecstatic. This heartwarming moment ...
By USA Today | 3 days ago -
France finally show grit but is this a turning point or simply a false dawn?
After France's 3-1 win against Italy, Didier Deschamps expressed pride in the team's performance. The match saw a revitalized lineup and a standout performance by Lucas Digne. Despite missing key play...
By The Guardian | 4 days ago -
Dawn's Early Light by Kevin Roberts review - weird vibes and pyromania from Project 2025 chief
In his book, Kevin Roberts of the Heritage Foundation advocates for a New Conservative Movement to revive American traditions. He pushes for a hard-right agenda and aims to empower "real Americans" to...
By The Guardian | 5 days ago
